Cargando…
Long-term follow-up of patients with advanced ovarian cancer treated in randomised clinical trials.
The data from two prospective randomised phase III trials that were initiated by the West Midlands Ovarian Cancer Study Group (WMOCSG) in 1981 and 1986, recruiting 167 and 195 patients respectively, have been pooled and the survival patterns of the 362 patients treated for advanced epithelial ovaria...
Autores principales: | Warwick, J., Kehoe, S., Earl, H., Luesley, D., Redman, C., Chan, K. K. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1995
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2034090/ https://www.ncbi.nlm.nih.gov/pubmed/8519669 |
Ejemplares similares
-
Single agent high-dose cisplatin (200 mg m-2) treatment in ovarian carcinoma.
por: Kehoe, S., et al.
Publicado: (1992) -
Analysis of randomised trials with long-term follow-up
por: Herbert, Robert D., et al.
Publicado: (2018) -
Long-term follow-up of Phase 2A trial results involving advanced ovarian cancer patients treated with Vigil® in frontline maintenance
por: Oh, Johnathan, et al.
Publicado: (2020) -
Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial
por: Menon, Usha, et al.
Publicado: (2021) -
Tumour cell activity markers in epithelial ovarian cancer: are biochemical and cytometric indices complementary?
por: Redman, C. W., et al.
Publicado: (1990)